Sub-lingual Immunotherapy: World Allergy Organization Position Paper 2009

Nettis E, Colanardi M, Soccio A, Marcandrea M, Pinto L, Ferrannini A . Double-blind, placebo-controlled study of sublingual immunotherapy in patients with latex-induced urticaria: a 12-month study. Br J Dermatol. 2007; 156(4):674-81. DOI: 10.1111/j.1365-2133.2006.07738.x. View

Tahamiler R, Saritzali G, Canakcioglu S . Long-term efficacy of sublingual immunotherapy in patients with perennial rhinitis. Laryngoscope. 2007; 117(6):965-9. DOI: 10.1097/MLG.0b013e31804f8141. View

Malling H, Alvarez-Cuesta E, Bjorksten B, Bousquet J, Caillot D, Canonica G . Local immunotherapy. Allergy. 1998; 53(10):933-44. DOI: 10.1111/j.1398-9995.1998.tb03793.x. View

Mothes N, Heinzkill M, Drachenberg K, Sperr W, Krauth M, Majlesi Y . Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies. Clin Exp Allergy. 2003; 33(9):1198-208. DOI: 10.1046/j.1365-2222.2003.01699.x. View

Herland K, Akselsen J, Skjonsberg O, Bjermer L . How representative are clinical study patients with asthma or COPD for a larger "real life" population of patients with obstructive lung disease?. Respir Med. 2005; 99(1):11-9. DOI: 10.1016/j.rmed.2004.03.026. View

Bernardis P, Agnoletto M, Puccinelli P, Parmiani S, POZZAN M . Injective versus sublingual immunotherapy in Alternaria tenuis allergic patients. J Investig Allergol Clin Immunol. 1996; 6(1):55-62. View

Caubet J, Eigenmann P . Late side-effects during systemic immunotherapy in children. Allergy. 2008; 63(11):1561-2. DOI: 10.1111/j.1398-9995.2008.01868.x. View

Bufe A, Eberle P, Franke-Beckmann E, Funck J, Kimmig M, Klimek L . Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy. J Allergy Clin Immunol. 2009; 123(1):167-173.e7. DOI: 10.1016/j.jaci.2008.10.044. View

Halken S, Lau S, Valovirta E . New visions in specific immunotherapy in children: an iPAC summary and future trends. Pediatr Allergy Immunol. 2008; 19 Suppl 19:60-70. DOI: 10.1111/j.1399-3038.2008.00768.x. View

10.

Lue K, Lin Y, Sun H, Lu K, Hsieh J, Chou M . Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study. Pediatr Allergy Immunol. 2006; 17(6):408-15. DOI: 10.1111/j.1399-3038.2006.00443.x. View

11.

Francis J, James L, Paraskevopoulos G, Wong C, Calderon M, Durham S . Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity. J Allergy Clin Immunol. 2008; 121(5):1120-1125.e2. DOI: 10.1016/j.jaci.2008.01.072. View

12.

Di Rienzo V, Minelli M, Musarra A, Sambugaro R, Pecora S, Canonica W . Post-marketing survey on the safety of sublingual immunotherapy in children below the age of 5 years. Clin Exp Allergy. 2005; 35(5):560-4. DOI: 10.1111/j.1365-2222.2005.02219.x. View

13.

HERXHEIMER H, Prior F . Further observations on induced asthma and bronchial hyposensitization. Int Arch Allergy Appl Immunol. 1952; 3(3):189-207. DOI: 10.1159/000227963. View

14.

Niederberger V, Horak F, Vrtala S, Spitzauer S, Krauth M, Valent P . Vaccination with genetically engineered allergens prevents progression of allergic disease. Proc Natl Acad Sci U S A. 2004; 101 Suppl 2:14677-82. PMC: 521981. DOI: 10.1073/pnas.0404735101. View

15.

Wachholz P, Durham S . Induction of 'blocking' IgG antibodies during immunotherapy. Clin Exp Allergy. 2003; 33(9):1171-4. DOI: 10.1046/j.1365-2222.2003.01765.x. View

16.

Platts-Mills T, Leung D, Schatz M . The role of allergens in asthma. Am Fam Physician. 2007; 76(5):675-80. View

17.

Canonica G, Poulsen P, Vestenbaek U . Cost-effectiveness of GRAZAX for prevention of grass pollen induced rhinoconjunctivitis in Southern Europe. Respir Med. 2007; 101(9):1885-94. DOI: 10.1016/j.rmed.2007.05.003. View

18.

Verhoef A, Alexander C, Kay A, Larche M . T cell epitope immunotherapy induces a CD4+ T cell population with regulatory activity. PLoS Med. 2005; 2(3):e78. PMC: 1069669. DOI: 10.1371/journal.pmed.0020078. View

19.

Caffarelli C, Sensi L, Marcucci F, Cavagni G . Preseasonal local allergoid immunotherapy to grass pollen in children: a double-blind, placebo-controlled, randomized trial. Allergy. 2000; 55(12):1142-7. DOI: 10.1034/j.1398-9995.2000.00655.x. View

20.

Gangemi S, Isola S, La Motta N, Puccinelli P, Parmiani S, Savi E . Sublingual immunotherapy: a double-blind, placebo-controlled trial with Parietaria judaica extract standardized in mass units in patients with rhinoconjunctivitis, asthma, or both. Allergy. 1999; 54(9):968-73. DOI: 10.1034/j.1398-9995.1999.00203.x. View